-
1.发明公开
公开(公告)号：EP2720684A2
公开(公告)日：2014-04-23
申请号：EP12758603.0
申请日：2012-06-13
申请人： Ipsen Pharma S.a.S.
发明人： RICHARD, Joël , LAREDJ, Faïza , BARONNET, Marie-Madeleine , NOURRISSON, Didier , HARNETT, Jeremiah , HACHER, Béatrice , MONDOLY, Nathalie , BERTOCCHI, Laurent
CPC分类号： A61K9/1652 , A61K9/0019 , A61K38/33
摘要： The present invention relates to a sustained-release drug composition consisting essentially of microparticles of a peptide as the active substance and a biocompatible water-soluble polymer, in particular peptide as meianocortin receptor ligand. The present invention relates also to an injection formulation comprising the sustained-release drug composition suspended in an injection medium.
-
公开(公告)号：EP2720684B1
公开(公告)日：2019-01-16
申请号：EP12758603.0
申请日：2012-06-13
申请人： IPSEN PHARMA S.A.S.
-
公开(公告)号：EP2280693A2
公开(公告)日：2011-02-09
申请号：EP09727964.0
申请日：2009-04-03
申请人： IPSEN PHARMA S.A.S.
CPC分类号： A61K9/19
摘要： The present invention relates to stable parenteral formulations comprising a new class of compounds, which is a non proteinic compound, a method for preparing such formulations as well as the use of certain compounds for stabilizing these formulations.
-
公开(公告)号：EP3810208A1
公开(公告)日：2021-04-28
申请号：EP19730839.8
申请日：2019-06-20
申请人： IPSEN PHARMA S.A.S.
-
5.发明公开AQUEOUS GELLING COMPOSITIONS OF SOLUBLE ACTIVE PHARMACEUTICAL PEPTIDES PROVIDING MODIFIED RELEASE 审中-公开WÄSSRIGEGELIERENDE ZUSAMMENSETZUNGENLÖSLICHERCLAVER PHARMAZEUTISCHER PEPTIDE MIT MODIFIZIERTER FREISETZUNG
公开(公告)号：EP2858626A1
公开(公告)日：2015-04-15
申请号：EP13727192.0
申请日：2013-06-06
申请人： IPSEN PHARMA S.A.S.
CPC分类号： A61K47/10 , A61K9/0019 , A61K9/0024 , A61K38/08 , A61K38/12 , A61K38/33 , C07K14/685
摘要： The present invention relates to an aqueous pharmaceutical composition comprising a peptide as the active ingredient, and one or more water-soluble or water-dispersible gelling agents.
摘要翻译： 本发明涉及包含肽作为活性成分的水性药物组合物和一种或多种水溶性或水分散性胶凝剂。
-
-
-
-
搜索结果
5 条记录 (耗时 0.01 秒)
